Invivyd, Inc. (IVVD)
0.6636
+0.06
(+9.18%)
USD |
NASDAQ |
Oct 15, 16:00
0.679
+0.02
(+2.32%)
After-Hours: 20:00
Invivyd EPS Diluted (Quarterly) : -0.1385 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1385 |
| March 31, 2026 | -0.1337 |
| December 31, 2025 | -0.0393 |
| September 30, 2025 | -0.0615 |
| June 30, 2025 | -0.1222 |
| March 31, 2025 | -0.1359 |
| December 31, 2024 | -0.1539 |
| September 30, 2024 | -0.5083 |
| June 30, 2024 | -0.3958 |
| March 31, 2024 | -0.3762 |
| December 31, 2023 | -0.6705 |
| September 30, 2023 | -0.3594 |
| Date | Value |
|---|---|
| June 30, 2023 | -0.4589 |
| March 31, 2023 | -0.3247 |
| December 31, 2022 | -0.4088 |
| September 30, 2022 | -0.4158 |
| June 30, 2022 | -0.4714 |
| March 31, 2022 | -0.9332 |
| December 31, 2021 | -0.7496 |
| September 30, 2021 | -0.5427 |
| June 30, 2021 | -0.4016 |
| March 31, 2021 | -0.3479 |
| December 31, 2020 | -0.1547 |
| September 30, 2020 | -0.4315 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.39M |
| Revenue (Quarterly) | 14.28M |
| Total Expenses (Quarterly) | 58.68M |
| Enterprise Value | 27.46M |
| Gross Profit Margin (Quarterly) | 86.62% |
| Profit Margin (Quarterly) | -310.8% |
| Earnings Yield | -56.21% |
| Normalized Earnings Yield | -56.21 |